Table 2.
Demographic characteristics (Cohort 2)
| AZCQ | AL | |
|---|---|---|
| N = 124 | N = 131 | |
| Male (n, %) | 74 (59.7) | 66 (50.4) |
| 6 months to <5 years (n, %) | 123 (99.2) | 129 (98.5) |
| 5 years (n, %)* | 1 (0.8) | 2 (1.5) |
| Age (years) mean (SD) | 2.4 (1.3) | 2.7 (1.0) |
| Range | 0.5-5.0 | 0.5-5.0 |
| Weight (kg) mean (SD) | 12.5 (3.1) | 12.8 (2.5) |
| Range | 6.1-19.0 | 6.9-18.0 |
| Height (cm), mean (SD) | 90.2 (11.6) | 92.7 (9.5) |
| Range | 59.0-115.0 | 66.3-116.0 |
| Body mass index (kg/m2) mean (SD) | 15.2 (1.6) | 14.9 (1.6) |
| Range | 9.5-20.7 | 8.4-20.3 |
AL = artemether-lumefantrine, AZCQ = azithromycin-chloroquine fixed-dose combination, SD = standard deviation.
*Three subjects who were 5 years of age were protocol violations.